Category: Market News

ECR Minerals (LSE:ECR) has commenced a multi-phase reconnaissance and target-generation programme at its 80%-owned Tuckanarra Gold Project in Western Australia. Located adjacent to Odyssey Gold’s 407,000-ounce JORC-compliant gold resource, the campaign is designed to improve geological knowledge of both primary gold mineralisation and paleochannel-hosted deposits across one of the company’s most prospective exploration assets.

The work is being carried out in partnership with the Australian Prospectors and Leaseholders Association (APLA) as part of ECR’s strategy to identify new drill-ready targets in a cost-effective manner.

Low-Cost Exploration Strategy Targets New Discoveries

The initial field programme will begin in August 2026 and run for approximately two weeks without generating additional direct costs for ECR. A larger follow-up campaign is scheduled for March 2027, when up to 80 field personnel are expected to participate in extensive mapping, sampling and metal detecting activities.

Information gathered during the exploration programme will be combined with ECR’s existing Deep Ground Penetrating Radar data and other geological datasets. Management expects the integrated approach to improve geological models, refine exploration priorities and identify the most promising areas for future geophysical surveys, trenching and drilling.

Exploration Data to Guide Future Development

The company believes the phased exploration strategy will maximise the value of its exploration budget by focusing future investment on the highest-priority targets. Improved geological understanding could also enhance the long-term development potential of the Tuckanarra project as exploration advances.

By combining low-cost fieldwork with existing technical data, ECR aims to increase confidence in prospective targets before committing to more capital-intensive exploration programmes.

Financial Position Remains a Key Consideration

Despite continued exploration activity, ECR’s outlook remains constrained by the absence of revenue, ongoing operating losses and continued cash outflows, indicating that additional funding may be required as projects progress.

Technical indicators also remain weak, with the shares trading below their major moving averages. However, the company continues to benefit from a debt-free balance sheet, while recent improvements in losses and cash burn provide some encouragement despite the broader financial challenges.

About ECR Minerals

ECR Minerals is an Australian-focused exploration and development company with projects across Queensland, Victoria, South Australia and Western Australia. Through its wholly owned subsidiaries, the company is advancing a portfolio of hard rock, alluvial and shallow open-pit gold assets, including the Tuckanarra, Bailieston, Creswick, Tambo, Maddens and Salt Bush projects.

Invinity Energy Systems (LSE:IES) has won its largest contract to date after securing an order for 43 MWh of vanadium flow battery systems from Dairyland Power Cooperative. The batteries will be deployed across several long-duration energy storage sites in the U.S. Midwest, where they are expected to improve grid resilience and reliability for customers across Dairyland’s predominantly rural electricity network.

The order will be supplied using Invinity’s Endurium battery technology, with deliveries scheduled to begin during the second half of 2027.

DOE-Backed Project Strengthens U.S. Presence

The project forms part of the REVIVE programme, which is supported by the U.S. Department of Energy and is designed to accelerate the deployment of long-duration energy storage technologies.

Management said the contract reflects increasing demand for energy storage systems capable of frequent deep cycling and long operational lifespans. The agreement also builds on Invinity’s recent commercial progress in the United States, following previous projects in California and Wisconsin, while further strengthening its order book and supporting its U.S. manufacturing strategy.

Long-Duration Storage Market Continues to Expand

The Dairyland Power agreement reinforces Invinity’s position in the growing market for utility-scale energy storage, where vanadium flow batteries are increasingly being adopted as an alternative to lithium-ion technology for applications requiring long operating lives and high durability.

The company believes continued investment in renewable energy infrastructure and grid modernisation will create further opportunities for its technology across North America and other international markets.

Profitability Remains the Key Challenge

Despite growing commercial momentum, Invinity continues to face financial challenges, including ongoing operating losses, negative profit margins and significant cash outflows. The company’s relatively low debt levels provide some financial flexibility, but achieving sustainable profitability remains a key objective.

Technical indicators also remain weak, with the shares trading below major moving averages and a negative MACD signalling continued bearish momentum, although oversold conditions may provide scope for a recovery. Management highlighted improving order intake, lower operating costs and a healthy liquidity position, but successful execution and stronger cash generation remain critical to the company’s longer-term outlook.

About Invinity Energy Systems

Invinity Energy Systems is a manufacturer of vanadium flow batteries for long-duration energy storage, with operations in the UK and Canada. Its Endurium battery systems are designed to provide a safer, longer-lasting alternative to lithium-ion technology, supporting heavy-duty applications over operating lives of up to 30 years.

The company’s products help utilities and energy providers improve grid stability, increase renewable energy integration and deliver reliable long-duration electricity storage for commercial and utility-scale projects worldwide.

Bezant Resources Plc (LSE:BZT) has announced that director Edward Slowey retired from the board and its subsidiary companies with effect from 31 July 2026, marking a leadership transition as the Hope and Gorob project progresses from the development stage into mining operations.

The company thanked Slowey for his contribution during the exploration, confirmation and pre-development phases of the project, recognising his role in advancing one of Bezant’s key assets.

Former Director to Continue Supporting Botswana Project

Although stepping down from the board, Slowey will continue to work with the company as a consultant on the Kanye manganese project in Botswana. Management said his ongoing involvement will provide continuity as Bezant continues to develop its portfolio of mineral assets across southern Africa.

The arrangement allows the company to retain valuable technical expertise while supporting the next stage of its operational growth.

Company Reaffirms Regulatory Compliance

Bezant also noted that the announcement contains inside information for the purposes of UK market abuse regulations, highlighting its continued compliance with corporate governance and disclosure requirements.

The leadership change comes at an important point in the company’s development as investors monitor progress at Hope and Gorob alongside advancement of its wider exploration and mining portfolio.

Financial Performance Remains the Main Challenge

Despite operational progress, Bezant’s outlook continues to be constrained by the absence of revenue, ongoing operating losses and persistent negative operating and free cash flow. The company maintains relatively modest leverage, providing some financial flexibility.

Technical indicators are more encouraging, with the share price trading above key moving averages and supported by a positive MACD. However, valuation remains difficult to assess given the company’s limited earnings quality and the absence of a dividend.

About Bezant Resources Plc

Bezant Resources Plc is a mining exploration and development company focused on projects across Namibia, Botswana and Zambia. Its portfolio includes the Hope and Gorob project in Namibia and the Kanye manganese project in Botswana, with the company seeking to advance exploration assets into production while expanding its presence in the southern African mining sector.

Clarkson PLC (LSE:CKN) reported its strongest-ever first-half financial performance, benefiting from favourable shipping market conditions and increased demand for its services amid disruption to global trade routes, including through the Strait of Hormuz. Revenue rose to £413.5 million during the first six months of 2026, while underlying profit before tax climbed to a record £61.5 million.

Underlying basic earnings per share increased to 147.6 pence, and the group ended the period with free cash resources of £154.6 million, highlighting the continued strength of its balance sheet and cash generation.

Dividend Increase Reflects Confidence in Full-Year Outlook

The board declared an interim dividend of 35 pence per share, extending Clarksons’ record of annual dividend growth to 24 consecutive years.

Management said it now expects full-year results to come in materially ahead of current market expectations, supported by the exceptional trading performance achieved during the first half of the year. Unlike a typical year, the company does not expect earnings to be heavily weighted towards the second half, reflecting the unusually strong market conditions experienced so far in 2026.

Strategic Acquisitions Expand Technology and Commodities Capabilities

Clarksons continued to strengthen its long-term growth strategy through the acquisitions of Link Group, Zuma Labs and Serpac International, broadening its capabilities across commodities, technology and artificial intelligence.

The company also announced changes to its senior leadership team. Niamh Staunton will join as Chief Financial Officer, while Harriet Oliver has been appointed Chief Operating Officer. The appointments follow the planned retirement of long-serving executive Jeff Woyda.

Diversified Business Supports Long-Term Growth

Management said ongoing geopolitical tensions and disruption to international trade routes have increased demand for the company’s market intelligence and advisory expertise, reinforcing Clarksons’ position as a trusted intermediary across global shipping and commodities markets.

The group believes its diversified business model, worldwide presence and continued investment in technology, digital capabilities and strategic acquisitions position it well to capture future growth opportunities while maintaining disciplined capital allocation and attractive shareholder returns.

Strong Fundamentals Continue to Support Investment Case

Clarksons continues to benefit from high operating margins, a low-leverage balance sheet and strong cash generation. Although growth in revenue, profits and cash flow has moderated compared with previous periods, the company’s overall financial quality remains robust.

Technical indicators remain positive, with the shares trading above their major moving averages and supported by a positive MACD. However, elevated RSI and stochastic readings suggest the stock may be approaching overbought territory in the near term. Valuation remains reasonable, although not especially inexpensive.

About Clarkson PLC

Clarkson PLC is a global provider of shipping services, maritime advisory, logistics and investment banking solutions serving the international shipping and offshore industries. Founded in 1852, the FTSE 250 company operates through more than 70 offices worldwide and employs over 2,250 people.

Its services include shipbroking, market research, financial advisory, logistics support and capital markets expertise, helping customers navigate global commodity markets and maritime trade. Through continued investment in technology, digital platforms and artificial intelligence, Clarksons is expanding its capabilities while reinforcing its position as a leading intermediary across the shipping, commodities and financial sectors.

Tracsis (LSE:TRCS) has agreed to sell its Events Transport Planning & Management division to private investment firm Connection Capital in a cash transaction with an enterprise value of £7.25 million. The business provides transport planning and traffic management services for major outdoor events and venues across the UK and operated as a largely standalone unit within Tracsis’ Data, Analytics, Consultancy and Events division.

During the financial year ended 31 July 2025, the business generated approximately £20.4 million in revenue and £1.9 million in adjusted EBITDA.

Disposal Supports Shift Towards Higher-Margin Software

The sale marks another step in Tracsis’ strategy of concentrating on scalable software solutions and increasing the proportion of recurring revenue generated across the group. Management believes the disposal will allow the company to focus more closely on technology-led products that offer stronger long-term growth potential and higher margins.

The transaction also simplifies the group’s operating structure while reinforcing its strategic emphasis on software and data-driven transport solutions.

Sale Proceeds to Reduce Debt Following Acquisition

Funds raised from the disposal will be used primarily to reduce net debt following Tracsis’ recently announced acquisition of Mistral Data. Strengthening the balance sheet is expected to improve the group’s financial flexibility while supporting continued investment in its core software platforms and future growth initiatives.

Management confirmed that trading expectations for the 2026 financial year remain unchanged.

Financial Stability Supports Long-Term Outlook

Tracsis continues to benefit from a solid financial position, supported by a healthy balance sheet and improving cash generation. The shares have also maintained a positive long-term technical trend.

However, profitability metrics remain relatively weak, while the company’s high price-to-earnings ratio and modest dividend yield limit valuation support despite its favourable strategic positioning.

About Tracsis

Tracsis is a UK transport technology company providing software, hardware and data-driven services to the rail, traffic management and wider transport sectors. Its products help customers improve operational efficiency, optimise infrastructure performance, enhance safety and deliver better passenger experiences.

The company operates across the UK and North America, offering transport software, analytics, geographic information systems (GIS) and data capture solutions to transport operators, infrastructure managers and public sector organisations.

EnSilica (LSE:ENSI) has been awarded a €1.7 million contract to deliver the second phase of a satellite communications application-specific integrated circuit (ASIC) programme for a leading European satellite manufacturer. The 10-month project will focus on developing the system architecture, advanced signal processing algorithms and a working demonstrator, further strengthening the company’s expertise in designing high-performance communications chips for the space sector.

New Programme Builds Satellite Technology Capabilities

The latest contract expands EnSilica’s involvement in the satellite payload programme and reinforces its position as a supplier of specialist semiconductor technology for complex space applications. By progressing into the next development stage, the company aims to deepen its technical capabilities while strengthening relationships within the European satellite industry.

Management believes the project will support future opportunities in the fast-growing market for advanced communications infrastructure.

EU 5G Satellite Project Opens New Growth Opportunities

Alongside the contract award, EnSilica has joined the European 5G-aNTeNna consortium, which is developing user terminal technology for the European Union’s IRIS² satellite constellation.

As part of the project, the company will provide application-specific standard products (ASSPs) for satellite user terminals, expanding its presence beyond satellite payload technology into the ground segment of Europe’s sovereign satellite communications network. The initiative also positions EnSilica to benefit from the emerging 5G non-terrestrial network (5G-NTN) market.

Financial Challenges Continue Despite Strategic Progress

Although EnSilica continues to secure strategically important contracts, its financial outlook remains constrained by declining revenue, ongoing losses and weaker free cash flow.

Technical indicators have improved considerably in recent months, reflecting stronger share price momentum. However, signs that the stock may be overbought suggest the potential for short-term volatility. Valuation also remains challenging given the company’s loss-making position and the absence of a dividend.

About EnSilica plc

EnSilica plc is a fabless semiconductor company specialising in the design of application-specific integrated circuits for communications, industrial, automotive and space applications. Its expertise spans radio frequency (RF), millimetre-wave, mixed-signal and complex digital chip design.

The company develops reusable intellectual property and silicon platforms to shorten product development cycles and reduce engineering risk for customers. EnSilica operates design centres in the UK, India, Brazil and Hungary, serving clients across international technology markets.

HICL Infrastructure (LSE:HICL) has reported a positive start to its financial year, with its investment portfolio performing in line with expectations and growth-focused assets benefiting from ongoing capital expenditure programmes that are supporting higher EBITDA. During the period, the company strengthened its position in Cross London Trains by acquiring an additional 6.65% interest for approximately £52 million, increasing its total ownership to 13.13%.

Management expects the larger stake to deliver a modest uplift in net asset value (NAV) per share while giving HICL greater influence over the governance of one of its key transport investments.

Strategy Targets Higher Long-Term Returns

At its capital markets seminar in July, HICL outlined the next stage of its strategic development, aiming to generate medium-term total shareholder returns of more than 10%. The company plans to achieve this through disciplined capital allocation and selective investment in higher-return infrastructure opportunities while maintaining its focus on essential core assets.

The board also reaffirmed its progressive dividend policy, maintaining dividend targets of 8.50 pence per share for the financial year ending March 2027 and 8.65 pence for 2028.

Strong Liquidity Supports Shareholder Returns

HICL continued its share buyback programme during the period, repurchasing shares at a meaningful discount to net asset value. Management also highlighted the company’s strong liquidity position, resilient cash flows from its public-private partnership (PPP) investments and favourable long-term trends supporting global infrastructure investment.

These factors are expected to provide a solid platform for future capital allocation and continued shareholder distributions.

Financial Strength Underpins Outlook

The company’s investment case continues to benefit from a debt-free balance sheet, positive free cash flow and an attractive valuation supported by a relatively low price-to-earnings ratio and a high dividend yield.

Technical indicators remain constructive, with the shares continuing to trade in an upward trend, although momentum measures suggest the stock may be approaching overbought territory. Revenue variability remains one of the principal risks to the company’s longer-term outlook.

About HICL Infrastructure PLC

HICL Infrastructure PLC is a London-listed infrastructure investment company managed by InfraRed Capital Partners. The company invests in a diversified portfolio of essential infrastructure assets, including transport, utilities, communications infrastructure and public-private partnership (PPP) projects.

Its strategy focuses on generating stable, inflation-linked cash flows and delivering progressive dividends through disciplined investment management and a well-diversified portfolio of long-term infrastructure assets.

Intercede Group (LSE:IGP) has secured approximately $2.6 million in new contract awards and renewals, while also identifying around $1.65 million of additional renewal opportunities extending through to early 2030. The latest agreements were generated through the company’s partner network and include a mix of software licences, subscription contracts and professional services projects for customers across government, defence and other critical sectors.

New Business Expands Public Sector Presence

The newly announced contracts cover deployments of Intercede’s MyID CMS platform through both perpetual and subscription licensing models. Customers include U.S. federal agencies, a multinational military alliance, European public sector organisations and clients based in the Middle East.

The company also secured a number of professional services engagements supporting existing customers in the defence, aerospace and U.S. government sectors, further strengthening long-term client relationships.

Strong Pipeline Supports FY2027 Outlook

Management said the latest contract wins demonstrate healthy pipeline conversion and provide positive momentum at the beginning of FY2027. Intercede continues to focus on growing recurring revenue by maintaining a balanced mix of software licences, subscriptions and consulting services.

The company believes this diversified commercial model positions it well for sustainable medium-term growth despite ongoing macroeconomic uncertainty and geopolitical risks.

Solid Profitability Offsets Softer Revenue Trends

Intercede’s outlook continues to benefit from strong profitability and a conservatively financed balance sheet with low leverage. However, recent declines in revenue and cash generation compared with 2024 remain areas for investors to monitor.

Technical indicators also remain relatively weak, with the shares trading below their major moving averages. While the valuation appears reasonable, with a price-to-earnings ratio of approximately 16.4, this has yet to fully offset concerns surrounding slowing growth and weaker market momentum.

About Intercede Group

Intercede Group is a cybersecurity software company specialising in digital identity and credential management solutions. Its flagship MyID platform helps organisations protect users and systems through secure identity registration, authentication and credential lifecycle management.

The company’s technology supports password security, public key infrastructure (PKI), FIDO authentication, one-time passwords and identity verification services for customers across government, defence, financial services, healthcare and other highly regulated industries worldwide.

RWS Holdings (LSE:RWS) has reached an agreement to acquire Acogroup, the parent company of European language services provider Acolad, in a transaction with an enterprise value of £22.4 million. The acquisition will bring a business generating approximately £182 million in annual revenue into the group, significantly expanding RWS’s presence across Western Europe and strengthening its relationships with multinational clients operating in regulated industries.

The acquired business will become part of RWS’s Transform division, where management plans to combine Acolad’s capabilities with its existing AI-powered language and content solutions.

Acquisition Aims to Accelerate AI-Driven Growth

The transaction values Acogroup at around two times its expected adjusted EBITDA for the financial year ending September 2027. Total consideration of £40.2 million will be financed through RWS’s existing credit facilities.

Management expects the acquisition to create opportunities to expand the use of its AI-based Generate and Protect platforms, broaden its interpreting services and increase investment in new technology products. The deal remains subject to regulatory approval in France and consultation with employee representative bodies, with completion expected during the first half of FY2027.

Strategic Benefits Offset Recent Trading Challenges

RWS believes the acquisition will strengthen its competitive position by expanding its customer base, increasing cross-selling opportunities and enhancing its portfolio of AI-enabled language services.

However, the company’s broader outlook continues to be affected by weaker financial performance, including declining revenue, pressure on margins and recent losses. Technical indicators also remain subdued, with the share price trading below key moving averages.

Despite these challenges, RWS continues to benefit from a relatively solid balance sheet and an attractive dividend yield, which provide some support for the investment case.

About RWS Holdings

RWS Holdings is a global provider of AI-powered language, content and intellectual property solutions, helping organisations communicate effectively across international markets. The company combines linguistic expertise with artificial intelligence to deliver translation, localisation, content management and language technology services for large enterprises.

Its portfolio includes AI-driven platforms such as Cultural Intelligence Layer and Language Weaver Pro, with a particular focus on highly regulated sectors where accuracy, compliance and multilingual content management are critical.

CelLBxHealth plc (LSE:CLBX) has announced that its Parsortix platform featured in an independent, peer-reviewed study demonstrating the technology’s ability to identify key antibody-drug conjugate (ADC) biomarkers on circulating tumour cells (CTCs) from patients with triple-negative breast cancer and epithelial ovarian cancer. The findings add to the growing body of evidence supporting the platform’s application in precision oncology and treatment monitoring.

Study Demonstrates Detection of Key Cancer Biomarkers

The research, carried out by investigators in Dublin and published in The Journal of Liquid Biopsy, showed that the Parsortix system successfully detected clinically relevant biomarkers including TROP-2, FRα and PD-L1 on circulating tumour cells. Importantly, the platform was able to identify these targets even on tumour cells with low EpCAM expression, highlighting its ability to capture a broader and more diverse population of CTCs than conventional approaches.

The results reinforce the technology’s potential value in monitoring the biological changes that occur during cancer treatment.

Opportunity in the Expanding ADC Market

CelLBxHealth believes the study supports the use of Parsortix as a minimally invasive tool for real-time biomarker assessment within the fast-growing antibody-drug conjugate market, where changes in target expression can influence treatment selection and effectiveness.

Management said the findings are consistent with the company’s strategy of focusing on high-value applications for circulating tumour cell analysis across research, pharmaceutical development and translational oncology. The additional clinical evidence could help strengthen relationships with drug developers and healthcare professionals seeking more advanced methods of monitoring patient response to therapy.

Financial Challenges Continue to Temper Outlook

Despite the positive scientific validation, CelLBxHealth continues to face significant financial headwinds. Weak financial performance and negative technical indicators remain the primary factors affecting the company’s overall outlook.

While recent corporate developments and progress highlighted during earnings updates provide some encouragement, concerns surrounding profitability and valuation continue to weigh on investor sentiment.

About CelLBxHealth plc

CelLBxHealth plc is a biotechnology company specialising in circulating tumour cell intelligence for cancer research, drug development and clinical oncology. Its patented Parsortix platform isolates circulating tumour cells from blood samples for downstream imaging, genomic and proteomic analysis, supporting the development of personalised cancer treatments.

The company generates revenue through sales of Parsortix instruments and consumables, laboratory services for clinical studies, assay development and the expansion of laboratory-developed testing programmes through both partnerships and internal initiatives.